Pegcetacoplan
APL2-PNH-209
Phase 2 small_molecule active
Quick answer
Pegcetacoplan for Paroxysmal Nocturnal Hemoglobinuria (PNH) is a Phase 2 program (small_molecule) at Apellis Pharmaceuticals with 2 ClinicalTrials.gov record(s).
Program details
- Company
- Apellis Pharmaceuticals
- Indication
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active